Subscribe

Prognostic Subgroups of Shipp et al for Diffuse Large Cell Lymphoma

Specialty:

Hematology Oncology

Objective:

ICD-10:

Description:

Shipp et al evaluated 121 patients with diffuse large cell lymphoma who were treated with b-BACOD or M-BACOD (methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine and dexamethasone). Patients could be separated into risk groups based on clinical findings, which correlated with survival. The authors are from Dana Farber Cancer Institute and Brigham and Women's Hospital in Boston.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone